These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8882829)
1. [Concepts for local therapy of restenosis]. Riessen R; Oberhoff M; Karsch KR Z Kardiol; 1996; 85 Suppl 1():87-98. PubMed ID: 8882829 [TBL] [Abstract][Full Text] [Related]
2. [Drug and instrumental therapeutic approaches for prevention of restenosis]. Höfling B; Huehns TY; Gonschior P; Nikol S Z Kardiol; 1995; 84 Suppl 4():151-8. PubMed ID: 8585268 [TBL] [Abstract][Full Text] [Related]
3. [Local drug administration systems, preclinical and clinical use: perspectives and limitations]. Gonschior P; Wilensky R; March K; Höfling B Z Kardiol; 1996 Mar; 85(3):155-65. PubMed ID: 8659193 [TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stent: the emerging technique for the prevention of restenosis. Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626 [TBL] [Abstract][Full Text] [Related]
5. [New strategies in the treatment of restenosis]. von Hodenberg E; Tost B; Scheffold T Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555 [TBL] [Abstract][Full Text] [Related]
6. [State of treatment of coronary artery disease by drug releasing stents]. Müller R; Büllesfeld L; Gerckens U; Grube E Herz; 2002 Sep; 27(6):508-13. PubMed ID: 12378395 [TBL] [Abstract][Full Text] [Related]
7. Current status of biodegradable stents. Tanguay JF; Zidar JP; Phillips HR; Stack RS Cardiol Clin; 1994 Nov; 12(4):699-713. PubMed ID: 7850839 [TBL] [Abstract][Full Text] [Related]
8. [New understanding in the prevention of post-coronary angioplasty restenosis]. Meerkin D; Bertrand OF; Klutstein MW Harefuah; 2000 Dec; 139(11-12):457-62. PubMed ID: 11341195 [No Abstract] [Full Text] [Related]
9. [Standards in interventional therapy of coronary artery disease]. Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393 [TBL] [Abstract][Full Text] [Related]
10. Restenosis related to percutaneous coronary intervention has been solved? Kivelä A; Hartikainen J Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432 [TBL] [Abstract][Full Text] [Related]
12. [Prospects of prevention of restenosis after coronary angioplasty]. Le Feuvre C; Tahlil O; Feldman LJ; Steg PG Ann Cardiol Angeiol (Paris); 1996; 45(7):383-8. PubMed ID: 8952733 [TBL] [Abstract][Full Text] [Related]
13. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era. Lepor NE; Madyoon H; Kereiakes D Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234 [TBL] [Abstract][Full Text] [Related]
14. [The role of ionized radiation in prevention of restenosis after coronary angioplasty]. Przewłocki T; Pieniazek P; Tracz W; Kostkiewicz M; Olszowska M; Podolec P Przegl Lek; 1997; 54(12):857-62. PubMed ID: 9591455 [TBL] [Abstract][Full Text] [Related]
15. [Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?]. Langberg CW; Solheim S; Hagen S Tidsskr Nor Laegeforen; 2000 Feb; 120(6):707-10. PubMed ID: 10806885 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents. Grube E; Buellesfeld L Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588 [TBL] [Abstract][Full Text] [Related]
17. Local paclitaxel delivery after coronary stenting in an experimental animal model. Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059 [TBL] [Abstract][Full Text] [Related]